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About the Palliative Care Outcomes Collaboration (PCOC)  
 
 
PCOC is a unique national program that utilises standardised validated clinical assessment tools to benchmark and measure outcomes in palliative care. Participation in 
PCOC is voluntary and assists palliative care service providers to improve practice and meet the Palliative Care Australia (PCA) Standards for Providing Quality Palliative 
Care for all Australians. PCOC is funded under the National Palliative Care Program and is supported by the Australian Government Department of Health and Ageing. 
 
PCOC is a collaboration between four centres, each with a Chief Investigator, and is divided into four zones for the purpose of engaging with palliative care service 
providers.  The four PCOC zones and their Chief Investigators are: 
 
    Central Zone    Professor Kathy Eagar, Australian Health Services Research Institute, University of Wollongong 
 
    North Zone        Professor Patsy Yates, Institute of Health and Biomedical Innovation, Queensland University of Technology 
South Zone        Professor David Currow, Department of Palliative and Supportive Services, Flinders University 
West Zone         Assistant Professor Claire Johnson, Cancer and Palliative Care Research and Evaluation Unit, University of WA 
 
 
The National office is located within the Australian Health Services Research Institute at the University of Wollongong. 
 
 
The items included in the PCOC dataset (Version 2) serve the dual purpose of: 
 
• Defining a common clinical language to allow communication between palliative care providers 
• Facilitating the routine collection of national palliative care data for the purpose of reporting and benchmarking to drive quality improvement 
The dataset includes the clinical assessment tools: Phase Type of Care, Palliative Care Problem Severity Score (PCPSS), Symptom Assessment Scale (SAS), Australia-
modified Karnofsky Performance Status Scale (AKPS) and Resource Utilisation Groups – Activities of Daily Living (RUG-ADL). These are used to measure the quality and 
outcomes of palliative care. For more information on the PCOC clinical tools or data items please visit www.pcoc.org.au
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Introduction 
 
PCOC aims to assist services to improve the quality of the palliative care they provide through the analysis and benchmarking of patient outcomes. In this, the twelfth 
PCOC report, data submitted for the July – December 2011 period are summarised and patient outcomes benchmarked to enable participating services to assess their 
performance and identify areas in which they may improve. 
 
This report is broken into three sections: 
 
Section 1 summarises each of the four major benchmark measures and subsets and presents national benchmarking results for these benchmarks 
Section 2 presents additional analysis for each of the sixteen benchmarks 
Section 3 provides descriptive analysis of the data items at each of the patient, episode and phase levels 
 
In each of the three sections, data and analysis for VIC is presented alongside the national figures for comparative purposes. The national figures reflect all palliative care 
services who submitted data for the July - December 2011 period. A full list of these services can be found at www.pcoc.org.au 
 
If you would like more information regarding this report please contact: 
The PCOC National Director, email: pcoc@uow.edu.au or phone (02) 4221 4411 
 
   
“PCOC is an excellent example of a national and voluntary programme using benchmarking to measure outcomes in palliative care” 
PRISMA (Reflecting the Positive DiveRsities of European PrIorities for ReSearch and Measurement in End-of-Life CAre) in their recent publication 
Outcome Measurement in Palliative Care – The Essentials, www.prismafp7.eu 
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Section 1 – VIC at a Glance  
 
Table 1  Summary of benchmark measures 1-3 
Measure Description Benchmark Inpatient Ambulatory & Community 
   VIC 
Score 
Benchmark  
Met? 
VIC 
Score 
Benchmark  
Met? 
1. Time from referral to contact Benchmark 1:    Patients contacted on same or following day 90% 85.6 No 47.6 No 
2. Time in unstable phase 
  
  
Benchmark 2.1: Unstable phases lasting  for  less than 7 days - first phase of episode 85% 88.0 Yes 69.1 No 
Benchmark 2.2: Unstable phases lasting  for  less than 7 days - not first phase of episode 90% 93.5 Yes 73.3 No 
Benchmark 2.3: Median time in unstable phase 2 days 2 days Yes 3 days No 
3. Change in pain 
PC Problem Severity Score 
(PCPSS) 
 
Symptom Assessment Score 
(SAS) 
Benchmark 3.1: Phases starting with absent/mild pain, that end with absent/mild pain 90% 81.7 No  77.5 No 
Benchmark 3.2: Phases starting with moderate/severe pain, that end with absent/mild pain 60% 54.1 No  56.2 No 
Benchmark 3.3: Phases starting with absent/mild pain, that end with absent/mild pain 90% 81.9 No  78.3 No 
Benchmark 3.4: Phases starting with moderate/severe pain, that end with absent/mild pain 60% 53.0 No  60.0 Yes 
 
Table 2  Summary of benchmark measure 4: Average improvement on the 2008 baseline national average (X-CAS) 
 
 
For more information on the 
benchmark measures, see 
Section 2 and Appendix B 
 
 
Clinical Tool Description Average improvement on baseline Benchmark met? 
PCPSS 
  
  
  
Benchmark 4.1: Pain 0.14 Yes 
Benchmark 4.2: Other symptoms 0.32 Yes 
Benchmark 4.3: Family/carer 0.16 Yes 
Benchmark 4.4: Psychological/spiritual 0.16 Yes 
SAS 
  
  
  
Benchmark 4.5: Pain 0.26 Yes 
Benchmark 4.6: Nausea 0.20 Yes 
Benchmark 4.7: Breathing 0.36 Yes 
Benchmark 4.8: Bowels 0.36 Yes 
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Section 2 – Benchmark Analysis 
 
Measure 1 – Time from referral to first contact 
 
Time from referral to first contact reports responsiveness of palliative care services to patient needs.  This benchmark was set after consultation with participants at the 
PCOC national benchmarking workshops in 2008.  Participants acknowledged that, whilst there is wide variation in the delivery of palliative care across the country, 
access to palliative care should be measured based on patient need rather than service availability.  As a result, services operating 5 days a week (Monday-Friday) are 
benchmarked against services operating 7 days a week. 
Benchmark 1: This measure relates to the time taken for patients to be contacted and clinically assessed, once the palliative care team has received the 
patient’s referral. To meet this benchmark, at least 90% of patients must be contacted within two days of receipt of referral. 
 
The time from referral to first contact is calculated as the time from the date referral received to either the date of first contact (if provided) or the episode start date.  
 
Table 3  Time from referral to first contact by episode type 
Time (in days) Inpatient Ambulatory & Community 
VIC % All Services % VIC % All Services % 
Within 2 days     1850     85.6     9503     90.6     1790     47.6     3521     53.0 
2-7 days      226     10.5      798      7.6     1243     33.0     2028     30.5 
8-14 days       34      1.6       72      0.7      443     11.8      655      9.9 
Greater than 14 days       51      2.4      112      1.1      288      7.7      440      6.6 
Average      1.5 Na      1.3 Na      3.1 Na      2.9 Na 
Median        1 Na        1 Na        2 Na        1 na 
Note: Episodes where referral date was not recorded are excluded from the table. In addition, all records where time from referral to first contact or time from first contact to episode start was greater than 7 
days were considered to be atypical and were assumed to equal 7 days for the purpose of calculating the average and median time. 
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Figure 1  Trend in time from referral to first contact measure 
 
Inpatient episodes for Inpatient episodes for VIC 
 
all services 
 
 
Ambulatory and community episodes for 
 
VIC Ambulatory and community episodes for 
 
all services 
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Measure 2 – Time in unstable phase 
 
The unstable phase type, by nature of its definition, alerts clinical staff to the need for urgent changes to the patient’s plan of care or that emergency intervention is 
required. Those patients assessed to be in the unstable phase require intense review for a short period of time. An unstable phase is triggered if: 
• A patient experiences a new, unanticipated problem, and/or 
• A patient experiences a rapid increase in the severity of an existing problem, and/or 
• A patient’s family/carers experience a sudden change in circumstances that adversely impacts the patients care 
Unstable phases are ended in one of two ways: 
• A new plan of care has been put in place, has been reviewed and does not require any additional changes. This does not necessarily mean that the 
symptom/crisis has been fully resolved. However, the clinical team will have a clear diagnosis and a plan for the patient’s care. In this situation, the patient will 
move to either the Stable or Deteriorating Phase 
• The patient is likely to die within a matter of days. In this situation, the patient will be moved into Terminal Phase 
There are three benchmarks relating to the time in unstable phase measure: 
Benchmark 2.1: This benchmark relates to unstable phases that are the first phase in an episode of care (for example, a patient is admitted to an inpatient 
palliative care unit and is immediately assessed as being in the unstable phase). To meet this benchmark, at least 85% of these unstable phases 
must last for less than 7 days. 
Benchmark 2.2: This benchmark relates to unstable phases that are not the first phase in an episode of care (for example, a patient’s condition changes during an 
episode of care, and the patient’s phase type is changed to unstable). To meet this benchmark, at least 90% of these unstable phases must last 
for less than 7 days. 
Benchmark 2.3: This benchmark relates to all unstable phases, regardless of where they occur in the episode. To meet this benchmark, the median length of all 
unstable phases must be 2 days or less. 
 
Table 4 presents descriptive data for these three benchmarks. 
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Table 4  Time in unstable phase by episode type and occurrence in episode 
Episode type Occurrence of 
unstable phase 
Number of unstable phases Percent unstable for < 7 days Median days in unstable phase 
 VIC All Services VIC All Services VIC All Services 
Inpatient First phase of episode       797  4958     88.0     84.8  2  2 
Not first phase of episode   490  2356     93.5     90.3  2  2 
Total unstable phases  1287  7314     90.1     86.5  2  2 
Ambulatory &  
Community 
First phase of episode       702  1123     69.1     59.6  3  4 
Not first phase of episode   565  1180     73.3     68.5  2  3 
Total unstable phases   1267  2303     71.0     64.1  3  3 
 
 
Interpretation hint:  
For VIC, 797 patients commenced their inpatient episode of care in the unstable phase. Of these unstable phases, 88% lasted for 
less than 7 days. This was higher than the 84.8% seen across all participating services. 
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Measure 3 – Change in pain 
 
Pain management is acknowledged as a core business of palliative care services.  The Palliative Care Problem Severity Score (PCPSS) and Symptom Assessment Scale 
(SAS) provide two different perspectives of pain: the SAS is patient rated, while the PCPSS is clinician rated. There are two benchmarks related to each tool: one relating 
to the management of pain for patients with absent or mild pain, and the other relating to the management of pain for patients with moderate or severe pain.  
 
Phase records must have valid start and end scores for the PCPSS and/or SAS clinical assessment tools to be included in the benchmarks. 
 
Benchmark 3.1: This benchmark relates to patients who have absent or mild pain at the start of their phase of palliative care, as rated via the PCPSS clinical tool. 
To meet this benchmark, 90% of these phases must end with the patient still experiencing only absent or mild pain. Table 5 shows trends in this 
benchmark over the last four reports. 
 
Table 5  Trends in Benchmark 3.1: Phases with absent or mild pain at start, which end with absent or mild pain (PCPSS) 
Episode type  VIC All Services 
 Report 9 Report 10 Report 11 Report 12 Report 9 Report 10 Report 11 Report 12 
Inpatient Number      771     1079     1660     1702     2860     3969     5153     5577     
%     78.9     79.5     81.9     81.7     79.0     79.0     82.1     81.6     
Ambulatory & 
Community 
Number      554     1310     1383     1332     1441     2415     2176     2339     
%     77.4     75.0     74.6     77.5     75.8     74.9     75.1     77.5 
 
Benchmark 3.2: This benchmark relates to patients who have moderate or severe pain at the start of their phase of palliative care, as rated via the PCPSS clinical 
tool. To meet this benchmark, 60% of these phases must end with the patient’s pain reduced to being absent or mild. Table 6 shows trends in 
this benchmark over the last four reports. 
 
Table 6  Trends in Benchmark 3.2:  Phases with moderate or severe pain at start, which end with absent or mild pain (PCPSS) 
Episode type  VIC All Services 
 Report 9 Report 10 Report 11 Report 12 Report 9 Report 10 Report 11 Report 12 
Inpatient Number      257      351      456      485     1257     1655     1858     1986     
%     56.0     59.2     53.9     54.1     44.0     46.6     48.0     53.6     
Ambulatory & 
Community 
Number      199      455      431      398      485      806      646      697     
%     61.8     58.9     58.7     56.2     55.7     57.5     57.3     55.4 
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Benchmark 3.3: This benchmark relates to patients who have absent or mild pain at the start of their phase of palliative care, as rated via the SAS clinical tool. To 
meet this benchmark, 90% of these phases end with the patient still experiencing only absent or mild pain.  Table 7 shows trends in this 
benchmark over the last four reports. 
 
Table 7  Trends in Benchmark 3.3: Phases with absent or mild pain at start, which end with absent or mild pain (SAS) 
Episode type  VIC All Services 
 Report 9 Report 10 Report 11 Report 12 Report 9 Report 10 Report 11 Report 12 
Inpatient Number      728      894     1460     1572     3370     4672     5902     6476     
%     80.5     79.0     80.4     81.9     79.8     78.8     81.8     82.5     
Ambulatory & 
Community 
Number      511     1308     1467     1394     1978     2825     2566     2816     
%     77.5     75.3     76.8     78.3     78.2     76.4     76.8     78.1 
 
 
Benchmark 3.4: This benchmark relates to patients who have moderate or severe pain at the start of their phase of palliative care, as rated via the SAS clinical 
tool. To meet this benchmark, 60% of these phases must end with the patient’s pain reduced to being absent or mild. Table 8 shows trends in 
this benchmark over the last four reports. 
 
Table 8  Trends in Benchmark 3.4: Phases with moderate or severe pain at start, which end with absent or mild pain (SAS) 
Episode type  VIC All Services 
 Report 9 Report 10 Report 11 Report 12 Report 9 Report 10 Report 11 Report 12 
Inpatient Number      185      218      409      403     1453     1912     2159     2216     
%     51.2     51.9     52.9     53.0     41.3     45.7     46.4     49.6     
Ambulatory & 
Community 
Number      158      408      411      383      591      846      708      787     
%     60.5     60.4     63.6     60.0     53.1     55.3     57.0     56.2 
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Figure 2  Change in pain benchmark measures - all phases 
 
 PCPSS Pain  PCPSS Pain 
  
 Absent/mild pain at both start and end of phase 
  
 SAS Pain  
 Mod/severe pain at start with absent/mild pain at end 
  
 SAS Pain 
  
 Absent/mild pain at both start and end of phase  Mod/severe pain at start with absent/mild pain at end 
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Measure 4 – Change in symptoms relative to the baseline national average (X-CAS) 
 
Measure 4 includes a suite of case-mix adjusted scores used to compare the change in symptoms for similar patients i.e. patients in the same phase who started with the 
same level of symptom. Eight symptoms are included this report: 
 
4.1. Pain - PCPSS 4.2. Other symptoms- PCPSS 4.3. Family/carer - PCPSS 4.4. Psychological/spiritual- PCPSS 
4.5. Pain - SAS 4.6 Nausea - SAS 4.7. Breathing - SAS 4.8. Bowels - SAS 
 
The suite of benchmarks included in Measure 4 are generally referred to as X-CAS
 
 – CAS standing for Case-mix Adjusted Score, and the X to represent that multiple 
symptoms are included. 
 
 
 
How to interpret X-CAS: 
 
The X-CAS benchmarks are calculated relative to a baseline reference period (currently July-December 2008). As a result: 
 
If X-CAS is greater than 0 then on average, the patients’ change in symptom was better than similar patients
If X-CAS is 
 in the baseline reference period.  
equal to 0 then on average, the patients’ change in symptom was about the same as similar patients
If X-CAS is 
 in the baseline reference period. 
less than 0 then on average, the patients’ change in symptom was worse than similar patients
 
 in the baseline reference period. 
As the X-CAS measures look at change in symptom, they are only able to be calculated on phases which ended in phase change or discharge (as the phase end scores are 
required to determine the change). Bereavement phases are excluded from the analysis.  
 
A more technical explanation of X-CAS is included in Appendix B. 
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Figure 3  Trend in average improvement on 2008 baseline - Palliative Care Problem Severity Score 
 
 
  Benchmark 4.1:  Pain - PCPSS  Benchmark 4.2: Other symptoms- PCPSS 
  
 Benchmark 4.3: Family/carer - PCPSS   Benchmark 4.4: Psychological/spiritual- PCPSS 
  
Note: Only services with 10 or more valid assessments are included in the above graphs. 
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Figure 4  Trend in average improvement on 2008 baseline - Symptom Assessment Scale 
 
 
 Benchmark 4.5:  Pain - SAS  Benchmark 4.6: Nausea - SAS 
  
  
 Benchmark 4.7: Breathing - SAS 
  
 Benchmark 4.8:  Bowels - SAS 
  
Note: Only services with 10 or more valid assessments are included in the above graphs.  
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Section 3 - Descriptive analysis 
 
There are three levels of PCOC data items – Patient, Episode and Phase. 
 
The broad detail is found at the patient level, where the data items look at patient demographics. 
 
At the episode level, the items focus on characterising each setting of palliative care. They also describe the reasons behind why and how palliative care episodes 
start/end, the level of support patients receive both before and after an episode and (where applicable) the setting in which the patient died.  
 
The clinical focus of PCOC is at the phase level. The items at this level describe the patient’s stage of illness, functional impairment as well as their levels of pain and 
symptom distress. The items at the phase level are used to quantify patient outcomes, and are the focus of the PCOC Benchmarks in the previous sections. 
 
This section provides an overview of the data submitted by VIC at each level for the current reporting period. Summaries of the national data are included for 
comparative purposes. 
 
 
 
 
  
Some tables throughout this section may be incomplete. This is because some items may not be applicable to a particular service or it may be due to data 
quality issues. 
 
Please use the following key when interpreting the tables: 
 
na   The item is not applicable 
u     The item was unavailable/unable to be calculated due to missing or invalid data. 
 
In addition, interpret all figures carefully as results may appear distorted due to low frequencies being represented as percentages. 
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Profile of palliative care patients 
 
The information collected on each patient includes Indigenous status, sex, main language spoken at home and country of birth.  Table 9 shows the Indigenous status for 
all patients for VIC and nationally.  Non-disclosure of Indigenous status can result in cultural issues not being identified. A number of programs exist that can assist 
services to encourage Indigenous persons to identify.    
 
Table 9  Indigenous Status - all patients 
Indigenous Status VIC % All Services % 
Aboriginal but not Torres Strait Islander origin       27      0.6      133      0.9 
Torres Strait Islander but not Aboriginal origin       13      0.3       25      0.2 
Both Aboriginal and Torres Strait Islander origin        5      0.1       13      0.1 
Neither Aboriginal nor Torres Strait Islander origin     4141     88.6    13749     93.0 
Not stated/inadequately described      490     10.5      867      5.9 
Total     4676    100.0    14787    100.0 
 
Table 10 shows a breakdown of malignant and non-malignant diagnosis for the patients for VIC and at the national level.  The development of Version 3 Data Set will 
include further opportunity to expand on diagnosis for both malignant and non-malignant categories.  
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Table 10  Primary diagnosis 
Diagnosis category Primary diagnosis VIC % of category % of total All Services % of category % of total 
Malignant                         Bone and soft tissue                117 3.1 2.5 244 2.1 1.7 
Breast                              341 9.1 7.3 990 8.4 6.7 
CNS                                 77 2.1 1.6 194 1.6 1.3 
Colorectal                          442 11.8 9.5 1297 11.0 8.8 
Gynaecological                      184 4.9 3.9 530 4.5 3.6 
Haematological                      241 6.4 5.2 659 5.6 4.5 
Head and neck                       221 5.9 4.7 679 5.8 4.6 
Lung                                743 19.8 15.9 2310 19.6 15.6 
Pancreas                            202 5.4 4.3 650 5.5 4.4 
Prostate                            242 6.5 5.2 780 6.6 5.3 
Skin                                132 3.5 2.8 444 3.8 3.0 
Other GIT                           328 8.8 7.0 929 7.9 6.3 
Other urological                    150 4.0 3.2 485 4.1 3.3 
Other malignancy                    234 6.2 5.0 622 5.3 4.2 
Unknown primary                     91 2.4 1.9 335 2.8 2.3 
Malignant - not further defined     0 0.0 0.0 660 5.6 4.5 
All malignant 3745 100.0 80.1 11808 100.0 79.9 
Non-malignant                     Cardiovascular                      150 17.8 3.2 530 20.7 3.6 
HIV/AIDS                            0 0.0 0.0 2 0.1 0.0 
Kidney failure                      82 9.7 1.8 272 10.6 1.8 
Neurological disease                200 23.7 4.3 540 21.1 3.7 
Respiratory failure                 148 17.6 3.2 434 17.0 2.9 
Other non-malignancy                263 31.2 5.6 685 26.8 4.6 
Non-malignant - not further defined 0 0.0 0.0 95 3.7 0.6 
All non-malignant 843 100.0 18.0 2558 100.0 17.3 
Not Stated - 88 100.0 1.9 421 100.0 2.8 
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Profile of palliative care episodes 
 
An episode of care is a period of contact between a patient and a palliative care service that is provided by one palliative care service and occurs in one setting – for the 
purposes of this report, either as an Inpatient or an Ambulatory and Community patient.  
 
An episode of care refers to the care received within one setting. An episode of palliative care begins on the day the patient is assessed face to face by the palliative care 
provider and there is agreement between the patient and the service. 
 
An episode of palliative care ends when: 
 
• the principal clinical intent of the care changes and the patient is no longer receiving palliative care 
• the patient is formally separated from the hospital/hospice/community or, 
• the patient dies 
 
Referral source refers to the service or organisation from which the patient was referred to for each individual episode of care. Table 11 presents referral source by 
episode type.  Review of referral source can identify opportunities to connect with referral sources that are currently lower than the national referral profile (e.g. a 
community service with few GP referrals may want to re-address referral or triage practices and look to working more collaboratively). 
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Table 11  Referral source by episode type 
Referral source Inpatient Ambulatory & Community 
VIC % All Services % VIC % All Services % 
Public hospital - other than inpatient palliative care unit      832     38.4     4927     45.6     1694     45.0     3367     43.4 
Self, carer(s), family or friends        9      0.4      268      2.5       94      2.5      205      2.6 
Private hospital - other than inpatient palliative care unit      210      9.7      761      7.0      905     24.0     1262     16.3 
Public palliative care inpatient unit/hospice       19      0.9      363      3.4       55      1.5      318      4.1 
Private palliative care inpatient unit/hospice       18      0.8       93      0.9       61      1.6      135      1.7 
General medical practitioner       16      0.7      555      5.1      193      5.1     1046     13.5 
Specialist medical practitioner      106      4.9      382      3.5      133      3.5      459      5.9 
Community-based palliative care agency      529     24.4     2186     20.2       43      1.1       98      1.3 
Community-based service       87      4.0      405      3.7       73      1.9      168      2.2 
Residential aged care facility       13      0.6       81      0.7      135      3.6      232      3.0 
Other        5      0.2      104      1.0      108      2.9      149      1.9 
Not stated/inadequately described      322     14.9      679      6.3      270      7.2      312      4.0 
Total     2166    100.0    10804    100.0     3764    100.0     7751    100.0 
 
 
Table 12  Place of death – ambulatory and community episodes 
Place of death VIC % All Services % 
Private residence      414 52.3         1152 54.8 
Residential aged care setting      205 25.9          360 17.1 
Other location*      117 14.8          390 18.5 
Not stated/inadequately described       55 7.0           201 9.6 
Total      791 100.0        2103 100.0 
* Includes patients who have died in a hospital setting without the episode of non-admitted palliative care being ended. Patients whose community  
  episode has  ended when admitted to hospital are excluded from this table. 
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Table 13 gives a summary of the length of episode for patients for VIC and nationally. The term “elapsed days” refers to the number of days between the episode 
starting and ending. For inpatient episodes, elapsed days and length of stay are equivalent. In the ambulatory and community settings, the number of elapsed days may 
more than the number of occasions of service. 
Table 13  Length of episode summary (elapsed days) 
Length of episode Inpatient Ambulatory & Community 
VIC All Services VIC All Services 
Average length of episode     13.0     11.9     31.7     33.7 
Median length of episode      7.0      7.0     17.0     21.0 
Note: Bereavement phase records are excluded and episodes that remain open at the end of the reporting period (and hence do not have an episode end date), are also excluded. In addition, any records 
where LOS was greater than 180 days were considered to be atypical and are excluded from the average calculations. The number of episodes excluded can be seen in Table 14. 
 
Table 14 details the length of episode in the number of elapsed days.   
 
Table 14  Length of episode breakdown (elapsed days) 
Length of episode Inpatient Ambulatory & Community 
VIC % All Services % VIC % All Services % 
Same day       78 3.7           454 4.3           352 9.7           629 8.7 
1-2 days      370 17.7         1980 18.9          344 9.4           545 7.5 
3-4 days      288 13.8         1382 13.2          243 6.7           419 5.8 
5-7 days      325 15.6         1670 15.9          301 8.3           563 7.8 
8-14 days      447 21.4         2304 22.0          459 12.6          912 12.6 
15-21 days      216 10.3         1104 10.5          278 7.6           590 8.2 
22-30 days      148 7.1           671 6.4           285 7.8           630 8.7 
31-60 days      158 7.6           691 6.6           539 14.8         1163 16.1 
61-90 days       31 1.5           139 1.3           308 8.4           621 8.6 
Greater than 90 days       26 1.2            80 0.8           536 14.7         1152 15.9 
Total     2087 100.0       10475 100.0        3645 100.0        7224 100.0 
Note: Bereavement phase records are excluded and episodes that remain open at the end of the reporting period (and hence do not have an episode end date), are also excluded. 
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Profile of palliative care phases 
 
The palliative care phase is the stage of the patient’s illness. Palliative care phases are not sequential and a patient may move back and forth between phases.  
Palliative care phases provide a clinical indication of the level of care required. There are five palliative care phases; stable, unstable, deteriorating, terminal and 
bereaved. 
 
 
Table 15  Number of phases by phase type and episode type 
Phase Inpatient Ambulatory & Community 
VIC % All Services % VIC % All Services % 
Stable                                    1592 29.4             7181 26.5             2790 42.4             5246 38.1 
Unstable                                  1287 23.8             7314 27.0             1267 19.3             2303 16.7 
Deteriorating                             1402 25.9             7088 26.1             2041 31.0             4864 35.4 
Terminal                                   826 15.3             4234 15.6              459 7.0              1208 8.8 
Bereaved                                  306 5.7              1318 4.9                23 0.3               134 1.0 
All phases         5413 100.0           27135 100.0            6580 100.0           13755 100.0 
 
 
Table 16  Average phase length (in days) by phase and episode type 
Phase Inpatient Ambulatory & Community 
VIC All Services VIC All Services 
Stable                            7.5      6.9      21.6         21.8 
Unstable                          3.2      3.6      6.2           8.6 
Deteriorating                     6.5      5.5      13.6         15.6 
Terminal                          1.9      2.2      2.4           2.8 
Bereaved                          1.1      1.2      1.7           2.3 
Note: Phase records where length of phase was greater than 90 days were considered to be atypical and are excluded from the average calculations. 
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Table 17  Profile of PC Problem Severity Scores at beginning of phase by phase type – inpatient episodes (percentages) 
Phase Problem severity VIC All Services 
 Absent Mild Moderate Severe Absent Mild Moderate Severe 
Stable                            Pain                    49.8     33.8     12.7      3.7     43.0 38.3 14.8  4.0 
Other Symptom           24.8     52.7     19.9      2.6     21.1 43.7 26.4  8.9 
Psychological/Spiritual 36.0     47.6     14.3      2.1     24.5 46.7 21.5  7.3 
Family/Carer            47.3     37.6     12.6      2.5     34.1 39.7 18.7  7.5 
Unstable                          Pain                    31.9     26.0     29.4     12.7     26.9 28.7 28.7 15.6 
Other Symptom           10.1     36.1     42.4     11.4      8.7 27.4 40.2 23.8 
Psychological/Spiritual 20.0     44.6     29.5      5.9     14.3 38.3 32.7 14.7 
Family/Carer            31.3     36.8     25.5      6.5     21.1 34.0 29.5 15.3 
Deteriorating                     Pain                   46.3     26.9     19.8      6.9     34.9 33.3 22.4  9.4 
Other Symptom           13.5     38.4     36.5     11.6     11.7 30.4 36.3 21.6 
Psychological/Spiritual 22.7     45.1     26.4      5.8     18.8 39.9 28.3 13.0 
Family/Carer            30.9     34.9     25.2      9.0     22.3 33.1 28.5 16.1 
Terminal                          Pain                    43.5     24.2     22.0     10.3     39.4 32.1 18.5 10.1 
Other Symptom           25.3     27.8     32.0     14.9     24.2 26.3 27.4 22.1 
Psychological/Spiritual 45.1     25.8     19.7      9.4     38.0 27.8 20.4 13.7 
Family/Carer            21.2     24.8     32.1     21.8     15.4 26.5 31.9 26.1 
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Table 18  Profile of PC Problem Severity Scores at beginning of phase by phase type – ambulatory and community episodes (percentages) 
Phase Problem severity VIC All Services 
 Absent Mild Moderate Severe Absent Mild Moderate Severe 
Stable                            Pain                    30.5     53.4     14.9      1.3     37.1 47.6 13.6  1.8 
Other Symptom           11.8     58.1     27.4      2.6     16.1 54.0 26.0  3.9 
Psychological/Spiritual 16.7     60.1     20.5      2.7     23.0 53.6 20.0  3.3 
Family/Carer            16.6     50.9     28.5      4.0     24.0 45.9 24.9  5.1 
Unstable                          Pain                    16.7     33.1     33.4     16.8     19.5 31.3 31.6 17.6 
Other Symptom            4.1     25.2     48.2     22.5      5.9 24.6 45.8 23.7 
Psychological/Spiritual  8.7     37.1     36.4     17.8     11.8 36.0 35.2 17.0 
Family/Carer            11.1     23.8     41.5     23.6     14.8 25.4 39.1 20.7 
Deteriorating                     Pain                   23.1     46.4     26.1      4.4     26.6 42.0 26.0  5.4 
Other Symptom            3.9     33.0     51.6     11.5      5.9 31.4 48.8 13.9 
Psychological/Spiritual  8.9     51.8     32.2      7.0     14.6 46.2 31.0  8.2 
Family/Carer             6.0     30.8     50.8     12.4     11.3 31.9 43.3 13.5 
Terminal                          Pain                    33.3     43.3     16.1      7.3     35.3 38.2 17.9  8.6 
Other Symptom           17.3     35.7     30.3     16.8     19.5 31.3 30.4 18.9 
Psychological/Spiritual 38.4     31.5     21.7      8.5     40.2 29.8 20.9  9.1 
Family/Carer             4.2     23.1     49.2     23.5      8.0 26.6 41.6 23.9 
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Figure 5  Total RUG-ADL at beginning of phase – inpatients 
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Figure 6  Total RUG-ADL at beginning of phase – ambulatory and community patients 
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RUG-ADL (shown on the previous two pages) consists of 4 items (bed mobility, toileting, transfers and eating) and should be assessed on admission, at phase change and 
at episode end. 
The Karnofsky Performance Status Scale used in PCOC is the Australia-modified version which is applicable to both inpatient and community palliative care. The 
Karnofsky Performance Scale assesses patient/client functioning and performance and can be used in determining prognosis /survival times. 
Karnofsky & RUG-ADL can be used together to provide a profile of both patient dependency, equipment requirements, need for allied health referrals and carer 
burden/respite requirements. 
 
Table 19  Karnofsky score at phase start by episode type 
Karnofsky score Inpatient Ambulatory & Community 
VIC % All Services % VIC % All Services % 
Comatose or barely rousable      442      8.7     2416      9.4      266      4.1      573      4.2 
Totally bedfast and requiring extensive nursing care     1014     19.9     4899     19.1      535      8.2     1200      8.9 
Almost completely bedfast      575     11.3     2920     11.4      439      6.7      863      6.4 
In bed more than 50% of the time      930     18.3     4130     16.1      798     12.2     1539     11.4 
Requires considerable assistance     1065     20.9     5102     19.9     1686     25.7     3164     23.4 
Requires occasional assistance      715     14.0     3341     13.0     1438     22.0     3114     23.0 
Cares for self      241      4.7     1048      4.1      785     12.0     1864     13.8 
Normal activity with effort       86      1.7      391      1.5      273      4.2      680      5.0 
Able to carry on normal activity; minor signs or symptoms       14      0.3      113      0.4       68      1.0      199      1.5 
Normal; no complaints; no evidence of disease        1      0.0        4      0.0        5      0.1       15      0.1 
Not stated/inadequately described       12      0.2     1333      5.2      257      3.9      334      2.5 
Total     5095    100.0    25697    100.0     6550    100.0    13545    100.0 
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Table 20 presents information relating to the manner in which stable phases ended, both for VIC and nationally. A stable phase will end if a patient moves into a 
different phase (phase change), is discharged or the patient dies. For those stable phases that ended because the patient was deemed to be in another phase (phase 
change), Figure 7 and Figure 8 summarise subsequent the phase that the patient moved into, for both the Inpatient and Ambulatory & Community settings respectively. 
This movement from one phase to another is referred to as Phase Progression. The phase progression information is derived by PCOC. The “Unknown” category has 
been included to account for situations where subsequent phase records have not been submitted to PCOC, meaning the phase progression cannot be determined. 
Similar information is presented for the unstable, deteriorating and terminal phases on the following pages. 
Table 20  How stable phases end 
Phase end reason Inpatient Ambulatory & Community 
VIC % All Services % VIC % All Services % 
Phase change (see figures below)                     959  60.2  4121  57.4  1944  69.7  3482  66.4 
Discharge/case closure              604  37.9  2903  40.4   735  26.3  1384  26.4 
Died                                 24   1.5   118   1.6   111   4.0   332   6.3 
Bereavement phase end                 3   0.2     7   0.1     0   0.0     2   0.0 
Not stated/inadequately described     2   0.1    32   0.4     0   0.0    46   0.9 
Total  1592 100.0  7181 100.0  2790 100.0  5246 100.0 
 
Figure 7  Stable phase progression – inpatient 
 
Figure 8  Stable phase progression -  ambulatory & community  
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Table 21  How unstable phases end 
Phase end reason Inpatient Ambulatory & Community 
VIC % All Services % VIC % All Services % 
Phase change (see figures below)                      1151  89.4  6389  87.4   878  69.3  1553  67.4 
Discharge/case closure               82   6.4   495   6.8   359  28.3   606  26.3 
Died                                 46   3.6   347   4.7    30   2.4   121   5.3 
Bereavement phase end                 8   0.6    11   0.2     0   0.0     3   0.1 
Not stated/inadequately described     0   0.0    72   1.0     0   0.0    20   0.9 
Total  1287 100.0  7314 100.0  1267 100.0  2303 100.0 
 
 
 
 
Figure 9  Unstable phase progression - inpatient 
 
 
Figure 10  Unstable phase progression -  ambulatory & community 
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Table 22  How deteriorating phases end 
Phase end reason Inpatient Ambulatory & Community 
VIC % All Services % VIC % All Services % 
Phase change  (see figures below)                        989  70.5  4817  68.0  1404  68.8  2699  55.5 
Discharge/case closure              116   8.3  1040  14.7   311  15.2  1346  27.7 
Died                                273  19.5  1183  16.7   324  15.9   780  16.0 
Bereavement phase end                23   1.6    37   0.5     0   0.0     5   0.1 
Not stated/inadequately described     1   0.1    11   0.2     2   0.1    34   0.7 
Total  1402 100.0  7088 100.0  2041 100.0  4864 100.0 
 
 
 
 
Figure 11  Deteriorating phase progression - inpatient 
 
 
Figure 12  Deteriorating phase progression - ambulatory & community 
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Table 23  How terminal phases end 
Phase end reason Inpatient Ambulatory & Community 
VIC % All Services % VIC % All Services % 
Phase change  (see figures below)                      136  16.5   489  11.5   130  28.3   275  22.8 
Discharge/case closure                3   0.4    93   2.2    41   8.9    88   7.3 
Died                                572  69.2  3437  81.2   287  62.5   837  69.3 
Bereavement phase end               113  13.7   212   5.0     1   0.2     4   0.3 
Not stated/inadequately described     2   0.2     3   0.1     0   0.0     4   0.3 
Total   826 100.0  4234 100.0   459 100.0  1208 100.0 
 
 
 
 
Figure 13  Terminal phase progression - inpatient 
 
 
Figure 14  Terminal phase progression - ambulatory & community 
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Appendix A – Summary of data included in this report 
 
A1 – Data Summary 
 
This report includes data from a total of 102 services. During the reporting period, data were provided for a total of 14787 patients who between them had 18555 
episodes of care and 40890 palliative care phases. These total numbers are determined by a data scoping method. This method looks at the phase level data first and 
includes all phases that ended within the current reporting period. The associated episodes and patients are then determined (Section A3 contains a more detailed 
explanation of this process). Table 24 shows the number of patients, episodes and phases included in this report – both for VIC and nationally. 
 
A consequence of the data scoping method is that it is likely that not all phases related to a particular episode are included in this report. Hence, the average number of 
phases per episode calculation shown in Table 24 may be an underestimate (due to episodes that cross-over 2 or more reporting periods) as it only includes phases that 
ended within the current reporting period. 
 
 
Table 24  Number and percentage of patients, episodes and phases - by episode type 
Episode Type 
  
Inpatient Ambulatory & Community Total 
VIC All Services VIC All Services VIC All Services 
Number of patients* 1913     9247     2951     6405 4676 14787 
Number of episodes 2166    10804     3764     7751 5930 18555 
Number of phases 5413    27135     6580    13755 11993 40890 
Percentage of patients* 40.9     62.5     63.1     43.3 100 100 
Percentage of episodes 36.5     58.2     63.5     41.8 100 100 
Percentage of phases 45.1     66.4     54.9     33.6 100 100 
Average number of  phases per episode** 2.4           2.4      1.7           1.7        2.0      2.1 
*     Patients seen in both settings are only counted once in the total column and hence numbers/percentages may not add to the total. 
**    Average number of phases per episode is only calculated for closed episodes and excludes bereavement phases.  
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A2 – Data Item Completion 
 
Overall, the quality of data submitted to PCOC is very good and, as shown in Tables 25, 26 and 27 below, the rate of data completion is very high.  In reviewing this table, 
it is important to note that in some cases some data items are not required to be completed. For example, place of death is only required for non-admitted patients who 
have died. Hence the complete column in the following tables only refers to the percentage of complete records where the data item was relevant.    
 
PCOC strongly encourages services to complete and submit the whole data set on every patient as non-completion may result in services being excluded from relevant 
benchmarking activities or erroneous conclusions being drawn. Low completion of data items may also distort percentages and tables in some sections. 
  
Table 25  Item completion- patient level 
Data item % Complete 
 VIC All Services 
Date of birth    100.0    100.0 
Sex     99.9     99.9 
Indigenous status     89.5     94.1 
Country of birth     87.8     93.0 
Main language     82.2     90.6 
Primary diagnosis     98.1     97.2 
 
Table 26  Item completion- episode level 
Data item % Complete 
 VIC All Services 
Date of first contact/assessment     99.9     95.6 
Referral date     99.9     92.3 
Referral source     90.0     94.7 
Episode start date    100.0    100.0 
Mode of episode start    100.0     99.2 
Accommodation at episode start     96.2     97.2 
Episode end date    100.0     99.6 
Level of support at episode start     99.3     81.9 
Mode of episode end     99.0     98.2 
Accommodation at episode end     75.2     84.8 
Level of support at episode end     97.9     96.7 
Place of death     93.0     90.4 
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Table 27  Item completion - phase level 
Data item Sub-Category  % Complete 
 (where applicable) VIC All Services 
Phase start date  -    100.0    100.0 
Phase  -    100.0    100.0 
RUG-ADL  
at phase start   
  
Bed Mobility     91.4     95.2 
Toileting     91.3     95.1 
Transfers     91.3     94.9 
Eating     91.2     94.4 
PC Problem Severity  
at phase start   
  
Pain     97.5     81.5 
Other Symptom     97.0     85.3 
Psychological/Spiritual     97.3     92.5 
Family/Carer     97.3     91.7 
Symptom Assessment 
Score  
at phase start   
  
  
  
  
Insomnia     81.1     88.5 
Appetite     87.6     90.1 
Nausea     87.4     90.5 
Bowels     86.0     89.9 
Breathing     87.0     90.4 
Fatigue     88.0     90.5 
Pain     88.5     90.9 
Phase end reason  -     99.9     99.4 
Karnofsky at phase start  -     97.7     95.8 
 
 
Some tables throughout this report may be incomplete. 
This is because some items may not be applicable to a 
particular service or it may be due to data quality issues. 
 
Please use the following key when interpreting the 
tables: 
 
na   The item is not applicable 
u  The item was unavailable/unable to be calculated due       
to missing or invalid data. 
 
In addition, interpret all figures carefully as results may 
appear distorted due to low frequencies being 
represented as percentages. 
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A3 – Data scoping methodology 
 
The method used to determine which data is included in a PCOC report looks at the phase level records first. All phase records that end
 
 within the 6 month reporting 
period are deemed to be “in scope” and would be included in the report. The episode and patient records associated with these phases are also deemed to be “in scope” 
and hence would also be included in the report. 
Figure 15 below displays four examples to help visualize this process. 
 
Figure 15  Diagram of the PCOC data scoping process 
 
 
In Example 1
 
, the patient (represented by the green line) has one episode (represented by the blue line). This episode has six phases (represented by the purple line 
segments). All six phases would be included in the report as they all end within the reporting period. Hence, the episode and patient would also be in the report. 
In Example 2
 
, the patient has two episodes - the first having six phases and the second having seven phases. Looking at the phases associated with the first episode, the 
last four will be included in the report (as they end within the reporting period). For the phases relating to the second episode, only the first three end within the period, 
so only these would be included in the report. Both of the episode records and the patient record would also be reported on. 
In Example 3
 
, the patient has one episode and five phases. Only the last three phases will be reported on as they are the only ones ending within the reporting period. 
The episode and patient records would be included in the report. 
In Example 4, the patient again has one episode and five phases. This time, only the first three phases will be included in the report. Again, the episode and patient 
records would be included in the report on as they have associated phases ending within the period. 
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Appendix B – Benchmark Notes 
 
B1 – Outline of Benchmark Measures and Targets 
 
There is strong sectoral support for national benchmarks and a consensus that such benchmarks can drive service innovation regardless of model of care. Benchmarking 
provides opportunities to understand the services that are provided, the outcomes patients experience and also to generate research opportunities focused on how to 
demonstrate variations in practice and outcomes. 
Beginning in the reporting period January to June 2009 (Report 7), PCOC introduced four benchmark measures into the routine PCOC reports: 
 
Measure Benchmark 
1. Time from referral to first contact   
  
90% of patients are contacted on the day of, or the day after referral 
 
2. Time in unstable phase 85% in their first phase remain unstable for less than 7 days 
90% in a subsequent phase remain unstable for less than 7 days 
The median time in unstable phase is 2 days or less 
3. Change in pain (both PCPSS and SAS) 90% of phases that start with absent/mild pain start pain have absent/mild end pain 
60% of phases  with moderate/severe start pain have absent/mild end pain 
 
4. Change in symptoms relative to the national average
  (8 symptoms are included) 
A score of 0 or above 
 
 
 
 
It is recognised that services aspire to achieve best practice, and to reflect this, current benchmarks have intentionally been set at a high level. Where a service does not 
meet the benchmark, PCOC has adopted a target of improvement of 10% per year.   
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B2 – National profile graphs 
 
In each national profile graph, the shaded reqion describes the national profile for that benchmark. VIC services are highlighted as dots on the graph. Graphs may have 
differing numbers of dots, caused by services not qualifying for inclusion in a particular benchmark. This may be caused by insufficient data item completion, or services 
not having any records falling into a particular category, for example, no phases starting with moderate/severe SAS pain. 
 
B3 – X-CAS technical notes 
 
The procedure for calculating X-CAS is as follows: 
 
Step 1. Using the baseline data, calculate the average change in symptom for all patients
Step 2. For each individual phase, calculate the change in symptom score (start score minus end score) 
 in the same phase, having the same symptom start score. This is 
 called the expected change. 
Step 3. For each individual phase, calculate the difference between their change in symptom score
Step 4. Average all of the values calculated in step 3  to produce the service’s Symptom Casemix-Adjusted Score (e.g. PCAS).  
 (calculated in step 2) and the relevant expected change 
 (calculated in step 1).  
 
Example: 
Phase PCPSS Pain  
at start 
PCPSS Pain  
at end 
Step 1: Expected PCPSS Pain change 
(from Report 6 National Database) 
Step2: PCPSS Pain change 
(start score minus end score) 
Step 3: Difference 
(Step 2 minus Step 1) 
Step 4: Average of values in step 3 
Stable 0 1 -0.8 -1 -0.2  
-0.2+0.9+0.4-0.4 
  = .175 
4 
Stable 1 1 -0.9 0 0.9 
Unstable 3 1 1.6 2 0.4 
Deteriorating 2 1 1.4 1 -0.4 
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